Literature DB >> 8610339

Skin allograft rejection in CD28-deficient mice.

K Kawai1, A Shahinian, T W Mak, P S Ohashi.   

Abstract

Costimulatory interactions between CD28 and the B7 family have been shown to augment T cell responses in general. To further assess the importance of the costimulatory signals generated through CD28, the allogeneic response was examined in CD28-deficient mice. T cells from CD28-deficient mice showed reduced proliferation and cytokine production in response to allogeneic stimulator cells in vitro. However, CD28-deficient T cells developed cytotoxic activity against allogeneic target cells in vitro and efficiently rejected skin allografts in vivo. These results suggest that the costimulatory signals through CD28 are not essential for the induction of alloreactive effector functions in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8610339     DOI: 10.1097/00007890-199602150-00003

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

1.  Evidence that calcineurin is rate-limiting for primary human lymphocyte activation.

Authors:  T D Batiuk; L Kung; P F Halloran
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 2.  CD28/B7 regulation of autoimmune diabetes.

Authors:  K G Herold; D J Lenschow; J A Bluestone
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

3.  Interactions between peripheral blood CD8 T lymphocytes and intestinal epithelial cells (iEC).

Authors:  F A Arosa; C Irwin; L Mayer; M de Sousa; D N Posnett
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

4.  Mycophenolic acid is a potent inhibitor of the expression of tumour necrosis factor- and tumour necrosis factor-receptor superfamily costimulatory molecules.

Authors:  Miranda M L Van Rijen; Herold J Metselaar; Martijn Hommes; Jan N M Ijzermans; Hugo W Tilanus; Jaap Kwekkeboom
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

5.  Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

Authors:  Shahram Salek-Ardakani; Ramon Arens; Rachel Flynn; Alessandro Sette; Stephen P Schoenberger; Michael Croft
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Tumor masses support naive T cell infiltration, activation, and differentiation into effectors.

Authors:  Elizabeth D Thompson; Hilda L Enriquez; Yang-Xin Fu; Victor H Engelhard
Journal:  J Exp Med       Date:  2010-07-26       Impact factor: 14.307

7.  CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.

Authors:  K Saoulli; S Y Lee; J L Cannons; W C Yeh; A Santana; M D Goldstein; N Bangia; M A DeBenedette; T W Mak; Y Choi; T H Watts
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

Review 8.  Costimulation blockade: current perspectives and implications for therapy.

Authors:  Gillian Kinnear; Nick D Jones; Kathryn J Wood
Journal:  Transplantation       Date:  2013-02-27       Impact factor: 4.939

9.  B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.

Authors:  F Fallarino; P E Fields; T F Gajewski
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

10.  Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis.

Authors:  Stefanie Scheu; Judith Alferink; Tobias Pötzel; Winfried Barchet; Ulrich Kalinke; Klaus Pfeffer
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.